TW200504088A - Avermectin B1 monosaccharide derivatives - Google Patents

Avermectin B1 monosaccharide derivatives

Info

Publication number
TW200504088A
TW200504088A TW093117009A TW93117009A TW200504088A TW 200504088 A TW200504088 A TW 200504088A TW 093117009 A TW093117009 A TW 093117009A TW 93117009 A TW93117009 A TW 93117009A TW 200504088 A TW200504088 A TW 200504088A
Authority
TW
Taiwan
Prior art keywords
avermectin
c12alkenyl
c12alkyl
tautomers
isomers
Prior art date
Application number
TW093117009A
Other languages
English (en)
Inventor
Thomas Pitterna
Pierre Jung
Kessabi Fiona Murphy
Jerome Cassayre
Laura Quaranta
Ottmar Franz Hueter
Original Assignee
Syngenta Participations Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syngenta Participations Ag filed Critical Syngenta Participations Ag
Publication of TW200504088A publication Critical patent/TW200504088A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
TW093117009A 2003-06-16 2004-06-14 Avermectin B1 monosaccharide derivatives TW200504088A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0313937.5A GB0313937D0 (en) 2003-06-16 2003-06-16 Avermectin B1 monosaccharide derivatives having an aminosulfonyloxy substituentin the 4'-position

Publications (1)

Publication Number Publication Date
TW200504088A true TW200504088A (en) 2005-02-01

Family

ID=27636648

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093117009A TW200504088A (en) 2003-06-16 2004-06-14 Avermectin B1 monosaccharide derivatives

Country Status (15)

Country Link
US (1) US7521429B2 (zh)
EP (1) EP1638984B1 (zh)
JP (1) JP4750698B2 (zh)
AR (1) AR045693A1 (zh)
AT (1) ATE370157T1 (zh)
CY (1) CY1106940T1 (zh)
DE (1) DE602004008281T2 (zh)
DK (1) DK1638984T3 (zh)
ES (1) ES2293276T3 (zh)
GB (1) GB0313937D0 (zh)
PL (1) PL1638984T3 (zh)
PT (1) PT1638984E (zh)
SI (1) SI1638984T1 (zh)
TW (1) TW200504088A (zh)
WO (1) WO2004111070A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200538461A (en) * 2004-04-07 2005-12-01 Syngenta Participations Ag Avermectin and avermectin monosaccharide substituted in the 4"-and 4'-position respectively
AU2011252987B2 (en) 2010-05-12 2013-05-02 Boehringer Ingelheim Animal Health USA Inc. Injectable parasiticidal formulations of levamisole and macrocyclic lactones
NZ612185A (en) 2010-12-07 2015-10-30 Merial Inc Topical combination formulations of macrocyclic lactones with synthetic pyrethroids

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4622313A (en) 1985-08-01 1986-11-11 Merck & Co., Inc. O-sulfate derivatives of avermectins and milbemycins having improved water solubility
US4833168A (en) * 1986-10-03 1989-05-23 Merck & Co., Inc. Avermectin reformatsky adducts
US4906619A (en) * 1988-07-22 1990-03-06 Merck & Co., Inc. Alkyl avermectin derivatives
NZ231773A (en) * 1988-12-23 1992-09-25 Merck & Co Inc Avermectin derivatives, preparation and parasiticidal pharmaceutical compositions thereof
US5208222A (en) 1991-03-28 1993-05-04 Merck & Co., Inc. 4"-and 4'-alkylthio avermectin derivatives
GB9205007D0 (en) * 1992-03-07 1992-04-22 Pfizer Ltd Antiparasitic agents
AR037938A1 (es) 2001-12-21 2004-12-22 Syngenta Participations Ag Derivados de avermectina b1 que tienen un substituyente de aminosulfoniloxilo en la posicion 4''

Also Published As

Publication number Publication date
ES2293276T3 (es) 2008-03-16
GB0313937D0 (en) 2003-07-23
US20060229263A1 (en) 2006-10-12
ATE370157T1 (de) 2007-09-15
CY1106940T1 (el) 2012-09-26
DE602004008281D1 (en) 2007-09-27
PT1638984E (pt) 2007-11-09
EP1638984A1 (en) 2006-03-29
DE602004008281T2 (de) 2008-05-15
US7521429B2 (en) 2009-04-21
JP4750698B2 (ja) 2011-08-17
JP2006527724A (ja) 2006-12-07
SI1638984T1 (sl) 2007-12-31
PL1638984T3 (pl) 2008-02-29
WO2004111070A1 (en) 2004-12-23
AR045693A1 (es) 2005-11-09
EP1638984B1 (en) 2007-08-15
DK1638984T3 (da) 2007-12-03

Similar Documents

Publication Publication Date Title
CA2506441A1 (en) 5-substituted-pyrazine or pyridine glucokinase activators
SG165995A1 (en) Phenol derivatives and their use as rotamase inhibitors
EG24831A (en) Pyrimidine compounds and their use.
MX281941B (en) Anthranilamide compounds, process for their production and pesticides containing them
CA2565660A1 (en) Ortho substituted aryl or heteroaryl amide compounds
GEP20094700B (en) Biphenyl derivatives, fungicidal composition containing it and method of controlling phytopathogenic microorganisms
MY142109A (en) Pyrimidine derivatives for the treatment of abnormal cell growth
NO20006221L (no) Fremgangsmåte for bekjempelse av skadedyr
NZ536734A (en) Spiroindolinepiperidine derivatives
GEP20094847B (en) Novel phenyl-propargylether derivatives
TW200607801A (en) Pyrimidine derivatives for the treatment of abnormal cell growth
WO2005105732A8 (en) Substituted methyl aryl or heteroaryl amide compounds
TW200612949A (en) Pyrimidine derivatives for the treatment of abnormal cell growth
CA2337825A1 (en) Disubstituted bicyclic heterocycles, the preparation thereof and their use as pharmaceutical compositions
SI1483246T1 (sl) 5-substituirani alkilaminopirazolni derivati kot pesticidi
EP1775289A4 (en) NEW IMIDAZOLIDINE DERIVATIVES
TW200600085A (en) External preparation
WO2003053988A3 (en) Avermectin b1 derivatives having an aminosulfonyloxy substituent in the 4''-position
EP1634874A4 (en) imidazolidine
WO1998005652A3 (en) Arthropodicidal and fungicidal cyclic amides
MXPA05007923A (es) Derivados de monosacaridos de avermectina que tienen propiedades pesticidas.
WO2008153042A1 (ja) 抗腫瘍剤
AU8811401A (en) Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient
NZ527568A (en) Salts of avermectins substituted in the 4"-position and having pesticidal properties
HU9202047D0 (en) Method for producing n-phenyl-thiourea derivatives and pharmaceutical prepartives containing these compounds as active agents